Between May 2007 and April 2008 , patients who received R0 hepatic resection for HBV-related HCC were randomly assigned to receive no treatment ( the control group , n = 100 ) or antiviral therapy ( adefovir 10 mg/d , the antiviral group , n = 100 ) .